Citigroup’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-383,486
| Closed | -$575K | – | 5050 |
|
|
2023
Q1 | $575K | Sell |
383,486
-89,998
| -19% | -$135K | ﹤0.01% | 2437 |
|
|
2022
Q4 | $473K | Buy |
473,484
+473,025
| +103,056% | +$472K | ﹤0.01% | 2573 |
|
|
2022
Q3 | $1K | Sell |
459
-576
| -56% | -$1.26K | ﹤0.01% | 4906 |
|
|
2022
Q2 | $3K | Sell |
1,035
-1,107
| -52% | -$3.21K | ﹤0.01% | 5035 |
|
|
2022
Q1 | $6K | Sell |
2,142
-6,734
| -76% | -$18.9K | ﹤0.01% | 4969 |
|
|
2021
Q4 | $41K | Sell |
8,876
-41,147
| -82% | -$190K | ﹤0.01% | 4400 |
|
|
2021
Q3 | $426K | Sell |
50,023
-111,123
| -69% | -$946K | ﹤0.01% | 2994 |
|
|
2021
Q2 | $2.64M | Buy |
161,146
+7,504
| +5% | +$123K | ﹤0.01% | 1886 |
|
|
2021
Q1 | $3.39M | Buy |
153,642
+141,700
| +1,187% | +$3.13M | ﹤0.01% | 1605 |
|
|
2020
Q4 | $369K | Buy |
11,942
+10,134
| +561% | +$313K | ﹤0.01% | 2842 |
|
|
2020
Q3 | $37K | Sell |
1,808
-1,220
| -40% | -$25K | ﹤0.01% | 3639 |
|
|
2020
Q2 | $47K | Sell |
3,028
-3,032
| -50% | -$47.1K | ﹤0.01% | 3808 |
|
|
2020
Q1 | $47K | Buy |
6,060
+3,011
| +99% | +$23.4K | ﹤0.01% | 3827 |
|
|
2019
Q4 | $44K | Buy |
3,049
+2,331
| +325% | +$33.6K | ﹤0.01% | 4051 |
|
|
2019
Q3 | $10K | Buy |
718
+260
| +57% | +$3.62K | ﹤0.01% | 4589 |
|
|
2019
Q2 | $7K | Sell |
458
-1,787
| -80% | -$27.3K | ﹤0.01% | 4832 |
|
|
2019
Q1 | $39K | Buy |
+2,245
| New | +$39K | ﹤0.01% | 4187 |
|